Search Results 531-540 of 21265 for anti-TNF drugs

  1. Secukinumab (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Secukinumab injection is used to treat moderate to severe plaque psoriasis in patients who may benefit from receiving phototherapy (ultraviolet light treatment) ...

  2. Levoketoconazole (Oral Route) Before Using - Mayo Clinic

    Your doctor may decide not to treat you with this medication or change some of the other medicines you take. ... Adalimumab; Albendazole; Allopurinol; Alprazolam ...

  3. Cough And Cold Combinations (Oral Route) Description and Brand Names - Mayo Clinic

    The main expectorant used in cough and cold medicines is guaifenesin. Other ingredients added as expectorants (for example, ammonium chloride, calcium iodide, ...

  4. Triamterene And Hydrochlorothiazide (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  5. Antimyasthenic (Oral Route, Parenteral Route) Description and Brand Names - Mayo Clinic

    These medicines are available only with your doctor's prescription. This product is available in the following dosage forms: Tablet, Extended Release; Solution ...

  6. A Study to Identify a Panel of Biomarkers to Predict Response to Anti PD-1 Therapy - Mayo Clinic

    The purpose of this study is to identify a panel of possible biomarkers to predict response to anti PD-1 therapy by establishing the progression free survival ...

  7. Fulvestrant (Intramuscular Route) Description and Brand Names - Mayo Clinic

    It is also used to treat HR positive breast cancer that has progressed or worsened after hormonal therapy.

  8. Diclofenac (Intravenous Route) Description and Brand Names - Mayo Clinic

    Diclofenac injection is a nonsteroidal anti-inflammatory drug (NSAID) used to treat adults with mild to moderate pain. It is used alone or given with other ...

  9. Data From Worldwide Trial of Two HER2-Positive Breast Cancer Drugs Shows That Trastuzumab Should Remain as Standard of Care - Mayo Clinic News Network

    Dual blockade using two anti-HER2 drugs only increased toxicity, said Dr. Perez. This new analysis compared use of lapatinib or trastuzumab alone, as well ...

  10. Mercaptopurine (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...